Dubai Telegraph - Drugs from the deep: scientists explore ocean frontiers

EUR -
AED 3.8756
AFN 72.200575
ALL 98.139539
AMD 411.532283
ANG 1.916419
AOA 962.319203
ARS 1053.188708
AUD 1.630218
AWG 1.899315
AZN 1.784231
BAM 1.955003
BBD 2.146925
BDT 127.068214
BGN 1.956891
BHD 0.397718
BIF 3140.020304
BMD 1.055175
BND 1.421121
BOB 7.348005
BRL 6.129194
BSD 1.063362
BTN 89.676253
BWP 14.428257
BYN 3.479882
BYR 20681.429409
BZD 2.143327
CAD 1.478495
CDF 3023.076626
CHF 0.936043
CLF 0.037472
CLP 1033.976525
CNY 7.638303
CNH 7.648689
COP 4726.12869
CRC 542.978712
CUC 1.055175
CUP 27.962137
CVE 110.22008
CZK 25.288011
DJF 189.351934
DKK 7.458214
DOP 64.043899
DZD 141.622416
EGP 52.009895
ERN 15.827625
ETB 129.779309
FJD 2.40258
FKP 0.83167
GBP 0.831235
GEL 2.880458
GGP 0.83167
GHS 17.173001
GIP 0.83167
GMD 74.917819
GNF 9164.265159
GTQ 8.216651
GYD 222.469334
HKD 8.212268
HNL 26.846059
HRK 7.526869
HTG 139.81302
HUF 408.163026
IDR 16774.7496
ILS 3.959224
IMP 0.83167
INR 89.068533
IQD 1392.932319
IRR 44414.948032
ISK 147.313122
JEP 0.83167
JMD 168.341393
JOD 0.748221
JPY 164.500191
KES 136.329796
KGS 90.952195
KHR 4308.244201
KMF 492.080753
KPW 949.658078
KRW 1481.418127
KWD 0.324772
KYD 0.886139
KZT 524.106404
LAK 23352.482837
LBP 95221.093219
LKR 310.793338
LRD 200.438313
LSL 19.102015
LTL 3.115657
LVL 0.638265
LYD 5.151876
MAD 10.572991
MDL 19.161191
MGA 4961.977776
MKD 61.584316
MMK 3427.167142
MNT 3585.4848
MOP 8.519528
MRU 42.330748
MUR 50.047248
MVR 16.302766
MWK 1843.848551
MXN 21.712439
MYR 4.735102
MZN 67.423993
NAD 19.102015
NGN 1777.041223
NIO 39.134051
NOK 11.764987
NPR 143.481165
NZD 1.799094
OMR 0.406253
PAB 1.063367
PEN 4.030158
PGK 4.274258
PHP 62.064863
PKR 295.443194
PLN 4.34422
PYG 8298.578641
QAR 3.87682
RON 4.97705
RSD 116.980897
RUB 103.919035
RWF 1459.505187
SAR 3.964662
SBD 8.846117
SCR 14.382386
SDG 634.688134
SEK 11.596378
SGD 1.419896
SHP 0.83167
SLE 24.073878
SLL 22126.461188
SOS 607.652355
SRD 37.226828
STD 21839.991486
SVC 9.304208
SYP 2651.158922
SZL 19.108032
THB 36.972803
TJS 11.329783
TMT 3.703664
TND 3.346836
TOP 2.471323
TRY 36.237853
TTD 7.226055
TWD 34.365466
TZS 2801.489873
UAH 43.929697
UGX 3902.409597
USD 1.055175
UYU 44.831729
UZS 13603.455994
VES 47.479192
VND 26796.168359
VUV 125.272516
WST 2.950778
XAF 655.689778
XAG 0.035082
XAU 0.000412
XCD 2.851663
XDR 0.801074
XOF 655.686672
XPF 119.331742
YER 263.580476
ZAR 19.275884
ZMK 9497.834156
ZMW 29.087146
ZWL 339.76591
  • CMSC

    0.0700

    24.61

    +0.28%

  • SCS

    -0.3000

    13.37

    -2.24%

  • NGG

    -0.7800

    62.12

    -1.26%

  • RBGPF

    59.2500

    59.25

    +100%

  • RIO

    -0.5800

    60.62

    -0.96%

  • GSK

    -0.4100

    35.11

    -1.17%

  • AZN

    0.1000

    65.29

    +0.15%

  • RELX

    -0.4700

    46.12

    -1.02%

  • CMSD

    -0.0200

    24.73

    -0.08%

  • RYCEF

    -0.0400

    7.07

    -0.57%

  • JRI

    0.0200

    13.24

    +0.15%

  • BCE

    -0.4800

    27.21

    -1.76%

  • BCC

    1.4200

    142.55

    +1%

  • BTI

    0.1800

    35.42

    +0.51%

  • VOD

    0.2800

    8.75

    +3.2%

  • BP

    0.4100

    28.57

    +1.44%

Drugs from the deep: scientists explore ocean frontiers
Drugs from the deep: scientists explore ocean frontiers / Photo: Boris HORVAT - AFP/File

Drugs from the deep: scientists explore ocean frontiers

Some send divers in speed boats, others dispatch submersible robots to search the seafloor, and one team deploys a "mud missile" -- all tools used by scientists to scour the world's oceans for the next potent cancer treatment or antibiotic.

Text size:

A medicinal molecule could be found in microbes scooped up in sediment, be produced by porous sponges or sea squirts -- barrel-bodied creatures that cling to rocks or the undersides of boats -- or by bacteria living symbiotically in a snail.

But once a compound reveals potential for the treatment of, say, Alzheimer's or epilepsy, developing it into a drug typically takes a decade or more, and costs hundreds of millions of dollars.

"Suppose you want to cure cancer -- how do you know what to study?" said William Fenical, a professor at Scripps Institution of Oceanography, considered a pioneer in the hunt for marine-derived medicines.

"You don't."

With tight budgets and little support from big pharma, scientists often piggyback on other research expeditions.

Marcel Jaspars of Scotland's University of Aberdeen said colleagues collect samples by dropping a large metal tube on a 5,000 metres (16,400 feet) cable that "rams" the seafloor. A more sophisticated method uses small, remotely operated underwater vehicles.

"I say to people, all I really want is a tube of mud," he told AFP.

This small but innovative area of marine exploration is in the spotlight at crucial UN high seas treaty negotiations, covering waters beyond national jurisdiction, which could wrap up this week with new rules governing marine protected areas crucial for protecting biodiversity.

Nations have long tussled over how to share benefits from marine genetic resources in the open ocean -- including compounds used in medicines, bioplastics and food stabilisers, said Daniel Kachelriess, a High Seas Alliance co-lead on the issue at the negotiations.

And yet only a small number of products with marine genetic resources find their way onto the market, with just seven recorded in 2019, he said. The value of potential royalties has been estimated at $10 million to $30 million a year.

But the huge biological diversity of the oceans means there is likely much more to be discovered.

"The more we look, the more we find," said Jaspars, whose lab specialises in compounds from the world's extreme environments, like underwater hydrothermal vents and polar regions.

- Natural origins -

Since Alexander Fleming discovered a bacteria-repelling mould he called penicillin in 1928, researchers have studied and synthesised chemical compounds made by mostly land-based plants, animals, insects and microbes to treat human disease.

"The vast majority of the antibiotics and anti-cancer drugs come from natural sources," Fenical told AFP, adding that when he started out in 1973, people were sceptical that the oceans had something to offer.

In one early breakthrough in the mid-1980s, Fenical and colleagues discovered a type of sea whip -- a soft coral -- growing on reefs in the Bahamas that produced a molecule with anti-inflammatory properties.

It caught the eye of cosmetics firm Estee Lauder, which helped develop it for use in its product at the time.

But the quantities of sea whips needed to research and market the compound ultimately led Fenical to abandon marine animals and instead focus on microorganisms.

Researchers scoop sediment from the ocean floor and then grow the microbes they find in the lab.

In 1991 Fenical and his colleagues found a previously-unknown marine bacterium called Salinispora in the mud off the coast of the Bahamas.

More than a decade of work yielded two anti-cancer drugs, one for lung cancer and the other for the untreatable brain tumour glioblastoma. Both are in the final stages of clinical trials.

Fenical -- who at 81 still runs a lab at Scripps -- said researchers were thrilled to have got this far, but the excitement is tempered by caution.

"You never know if something is going to be really good, or not at all useful," he said.

- New frontiers -

That long pipeline is no surprise to Carmen Cuevas Marchante, head of research and development at the Spanish biotech firm PharmaMar.

For their first drug, they started out by cultivating and collecting some 300 tonnes of the bulbous sea squirt.

"From one tonne we could isolate less than one gram" of the compound they needed for clinical trials, she told AFP.

The company now has three cancer drugs approved, all derived from sea squirts, and has fine-tuned its methods for making synthetic versions of natural compounds.

Even if everything goes right, Marchante said, it can take 15 years between discovery and having a product to market.

Overall, there have been 17 marine-derived drugs approved to treat human disease since 1969, with some 40 in various stages of clinical trials around the world, according to the online tracker Marine Drug Pipeline.

Those already on the market include a herpes antiviral from a sponge and a powerful pain drug from a cone snail, but most treat cancer.

That, experts say, is partly because the huge costs of clinical trials -- potentially topping a billion dollars -- favours the development of more expensive drugs.

But there is a "myriad" of early-stage research on marine-derived compounds for anything from malaria to tuberculosis, said Alejandro Mayer, a pharmacology professor at Illinois' Midwestern University who runs the Marine Pipeline project and whose own speciality is the brain's immune system.

That means there is still huge potential to find the next antibiotic or HIV therapy, scientists say.

It might be produced by a creature buried in ocean sediment or quietly clinging to a boat's hull.

Or it could be already in our possession: laboratories around the world hold libraries of compounds that can be tested against new diseases.

"There's a whole new frontier out there," said Fenical.

A.Krishnakumar--DT